PRIO WEALTH LIMITED PARTNERSHIP - GLAXOSMITHKLINE PLC ownership

GLAXOSMITHKLINE PLC's ticker is GSK and the CUSIP is 37733W105. A total of 36 filers reported holding GLAXOSMITHKLINE PLC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.5%.

Quarter-by-quarter ownership
PRIO WEALTH LIMITED PARTNERSHIP ownership history of GLAXOSMITHKLINE PLC
ValueSharesWeighting
Q2 2022$205,505
+99659.7%
4,7210.0%0.01%
+14.3%
Q1 2022$206
-99.9%
4,721
+1.6%
0.01%
+16.7%
Q4 2021$205,000
-6.8%
4,646
-20.5%
0.01%
-33.3%
Q3 2020$220,000
-7.6%
5,8460.0%0.01%
-18.2%
Q2 2020$238,000
+1.7%
5,846
+1.1%
0.01%0.0%
Q3 2017$234,000
-6.0%
5,7850.0%0.01%
-8.3%
Q2 2017$249,000
+7.3%
5,785
+4.8%
0.01%0.0%
Q1 2017$232,000
-2.9%
5,519
-11.3%
0.01%
-7.7%
Q4 2016$239,000
-20.9%
6,219
-11.4%
0.01%
-18.8%
Q3 2016$302,000
-0.7%
7,0190.0%0.02%
-5.9%
Q2 2016$304,000
+7.0%
7,0190.0%0.02%
+13.3%
Q1 2016$284,000
-5.6%
7,019
-6.1%
0.02%
-6.2%
Q4 2015$301,000
-2.9%
7,473
-7.4%
0.02%
-11.1%
Q3 2015$310,000
-9.9%
8,073
-2.4%
0.02%0.0%
Q2 2015$344,000
-9.7%
8,2730.0%0.02%
-5.3%
Q1 2015$381,000
+7.9%
8,2730.0%0.02%
+5.6%
Q4 2014$353,000
-7.1%
8,273
-0.2%
0.02%
-10.0%
Q3 2014$380,000
-14.2%
8,2870.0%0.02%
-9.1%
Q2 2014$443,000
+0.2%
8,287
+0.2%
0.02%0.0%
Q1 2014$442,000
+0.2%
8,2730.0%0.02%0.0%
Q4 2013$441,000
+6.3%
8,2730.0%0.02%
-8.3%
Q3 2013$415,000
+0.5%
8,2730.0%0.02%
-4.0%
Q2 2013$413,0008,2730.02%
Other shareholders
GLAXOSMITHKLINE PLC shareholders Q3 2022
NameSharesValueWeighting ↓
JTC Employer Solutions Trustee Ltd 5,993,336$264,217,00032.64%
Black Creek Investment Management Inc. 10,373,943$457,491,00012.20%
KAHN BROTHERS GROUP INC 1,438,569$63,440,893,0008.71%
EQUITY INVESTMENT CORP 2,932,078$129,305,0004.68%
JET CAPITAL INVESTORS L P 400,000$17,640,0004.67%
Eversept Partners, LP 1,503,700$66,313,1704.24%
NKCFO LLC 269,500$11,885,0003.82%
Camber Capital Management LP 2,500,000$110,250,0003.79%
CLIFFORD CAPITAL PARTNERS LLC 113,866$5,021,0003.75%
Robinson Value Management, Ltd. 97,677$4,308,0003.54%
View complete list of GLAXOSMITHKLINE PLC shareholders